financetom
Business
financetom
/
Business
/
Eve Secures $150 Million in Financing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eve Secures $150 Million in Financing
Mar 11, 2026 1:04 AM

07:59 AM EST, 01/20/2026 (MT Newswires) -- Eve (EVEX) said Tuesday that it has secured a five-year, $150 million loan from Itau, Banco do Brasil, Citibank, and Mitsubishi UFJ Financial Group.

The company said the proceeds from the loan will support its research and development, including integrating its electric vertical take-off and landing aircraft into a "comprehensive urban air mobility ecosystem."

Eve said the funds will accelerate its technological progress and support its partnerships with infrastructure providers and regulatory organizations, as well as advance aircraft certification and commercialization.

Including the loan, Eve's total funding is $1.2 billion, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Gemini Space Station Q4 Loss Narrows, Revenue Rises
Update: Gemini Space Station Q4 Loss Narrows, Revenue Rises
Mar 20, 2026
04:40 AM EDT, 03/20/2026 (MT Newswires) -- (Updates with additional details in the fifth and sixth paragraphs and the stock movement in the seventh paragraph.) Gemini Space Station ( GEMI ) reported a Q4 loss late Thursday of $1.22 per diluted share, narrowing from a loss of $5.49 a year earlier. Analysts surveyed by FactSet expected a loss of $1.04....
Novartis to buy experimental breast cancer drug in up to $3 billion deal
Novartis to buy experimental breast cancer drug in up to $3 billion deal
Mar 20, 2026
FRANKFURT, March 20 (Reuters) - Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm Synnovation Therapeutics, adding a targeted therapy to its pipeline of cancer drugs. The company will pay $2 billion upfront and up to $1 billion that is contingent on further development achievements as part...
Antero Resources Insider Sold Shares Worth $528,000, According to a Recent SEC Filing
Antero Resources Insider Sold Shares Worth $528,000, According to a Recent SEC Filing
Mar 20, 2026
04:40 AM EDT, 03/20/2026 (MT Newswires) -- Benjamin A. Hardesty, Director, on March 19, 2026, sold 12,000 shares in Antero Resources ( AR ) for $528,000. Following the Form 4 filing with the SEC, Hardesty has control over a total of 150,742 common shares of the company, with 150,242 shares held directly and 500 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433270/000110465926032266/xslF345X05/tm269417-1_4seq1.xml ...
Nerdwallet Insider Sold Shares Worth $742,774, According to a Recent SEC Filing
Nerdwallet Insider Sold Shares Worth $742,774, According to a Recent SEC Filing
Mar 20, 2026
04:40 AM EDT, 03/20/2026 (MT Newswires) -- Samuel Yount, Chief Business Officer, on March 17, 2026, sold 71,988 shares in Nerdwallet ( NRDS ) for $742,774. Following the Form 4 filing with the SEC, Yount has control over a total of 607,551 Class A common shares of the company, with 433,578 shares held directly and 173,973 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved